Azithramycine

Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.

Cross Reference

Introduction

To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Azithramycine?

Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Azithramycine

MeSH term MeSH ID Detail
Cytomegalovirus Infections D003586 7 associated lipids
Gonorrhea D006069 7 associated lipids
Serum Sickness D012713 7 associated lipids
Mucositis D052016 7 associated lipids
Gingival Overgrowth D019214 7 associated lipids
Chlamydia Infections D002690 7 associated lipids
Pelvic Pain D017699 7 associated lipids
Corynebacterium Infections D003354 7 associated lipids
Chronic Disease D002908 7 associated lipids
Keratitis D007634 7 associated lipids
Stomach Diseases D013272 7 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Bronchiolitis Obliterans D001989 8 associated lipids
Lymphadenitis D008199 8 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Community-Acquired Infections D017714 8 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Skin Diseases, Bacterial D017192 8 associated lipids
Enteritis D004751 8 associated lipids
Leprosy D007918 8 associated lipids
Opportunistic Infections D009894 8 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Infant, Newborn, Diseases D007232 9 associated lipids
Rhabdomyolysis D012206 9 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Sinusitis D012852 9 associated lipids
Toxoplasmosis D014123 9 associated lipids
Keratosis D007642 9 associated lipids
Tooth, Impacted D014095 9 associated lipids
Otitis Media with Effusion D010034 9 associated lipids
Cross Infection D003428 9 associated lipids
Urethritis D014526 9 associated lipids
Pancreatitis D010195 10 associated lipids
Long QT Syndrome D008133 10 associated lipids
Precursor Cell Lymphoblastic Leukemia-Lymphoma D054198 10 associated lipids
Respiratory Insufficiency D012131 10 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Dyspnea D004417 10 associated lipids
Lung Diseases, Obstructive D008173 10 associated lipids
Osteitis D010000 10 associated lipids
Nephritis, Interstitial D009395 10 associated lipids
Dry Eye Syndromes D015352 10 associated lipids
Hearing Disorders D006311 10 associated lipids
Osteomyelitis D010019 10 associated lipids
Abnormalities, Drug-Induced D000014 10 associated lipids
Exanthema D005076 11 associated lipids
Shock, Septic D012772 11 associated lipids
Hyperbilirubinemia D006932 11 associated lipids
Scalp Dermatoses D012536 11 associated lipids
Per page 10 20 50 100 | Total 276

PubChem Associated disorders and diseases

What pathways are associated with Azithramycine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Azithramycine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Azithramycine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Azithramycine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Azithramycine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Azithramycine?

Mouse Model

Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).

Knock-out

Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).

Tissue Model

Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Azithramycine

Download all related citations
Per page 10 20 50 100 | Total 4404
Authors Title Published Journal PubMed Link
Fortner JH et al. Tapetal effect of an azalide antibiotic following oral administration in beagle dogs. 1993 Fundam Appl Toxicol pmid:8405779
Narcio Reyes LE et al. [Efficacy and safety of azithromycin in the treatment of female genital Chlamydia trachomatis infections]. 1993 Ginecol Obstet Mex pmid:8406112
Donowitz GR and Earnhardt KI Azithromycin inhibition of intracellular Legionella micdadei. 1993 Antimicrob. Agents Chemother. pmid:8285604
Kobrehel G et al. 9a,11-cyclic carbamates of 15-membered azalides. 1993 J. Antibiot. pmid:8407586
Fass RJ Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance. 1993 Antimicrob. Agents Chemother. pmid:8257127
Lopatkin NA et al. [Use of azithromycin ("Sumamded") in the treatment of infectious-inflammatory diseases of the lower urinary tract and male genitalia]. 1993 Antibiot. Khimioter. pmid:8060189
Saba J et al. Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS. 1993 Eur. J. Clin. Microbiol. Infect. Dis. pmid:8112357
Lefèvre JC et al. In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis. 1993 Pathol. Biol. pmid:8233628
Agacfidan A et al. In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae. 1993 Antimicrob. Agents Chemother. pmid:8239579
Lazarova Z et al. Azithromycin (Sumamed-Pliva) in the treatment of chlamydial genital tract infections in infertile marriages. 1992 Nov-Dec Int J STD AIDS pmid:1337473
Martin DH et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. 1992 N. Engl. J. Med. pmid:1325036
Gingras BA and Jensen JB Activity of azithromycin (CP-62,993) and erythromycin against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro. 1992 Am. J. Trop. Med. Hyg. pmid:1326232
Cynamon MH and Klemens SP Activity of azithromycin against Mycobacterium avium infection in beige mice. 1992 Antimicrob. Agents Chemother. pmid:1329622
Ballow CH and Amsden GW Azithromycin: the first azalide antibiotic. 1992 Ann Pharmacother pmid:1330097
Nilsen A et al. A double blind study of single dose azithromycin and doxycycline in the treatment of chlamydial urethritis in males. 1992 Genitourin Med pmid:1330880
Jones AB and Herbert CM The in vitro profile of selected 14-membered azalides. 1992 J. Antibiot. pmid:1334956
Engel JN Azithromycin-induced block of elementary body formation in Chlamydia trachomatis. 1992 Antimicrob. Agents Chemother. pmid:1280057
Peters DH et al. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. 1992 Drugs pmid:1280567
Frank MO et al. In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes. 1992 Antimicrob. Agents Chemother. pmid:1336337
O'Reilly T et al. Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin. 1992 Antimicrob. Agents Chemother. pmid:1336342